Request for Covid-19 Impact Assessment of this Report
In the last several years, global market of Hydroxycarbamide developed rapidly, with an average growth rate of 5.72%. In 2016, global revenue of Hydroxycarbamide is nearly 180 M USD; the actual production is about 1760 M Unit.
The major players in global Hydroxycarbamide market include
Bristol Myers Squibb
Taj Pharma
Beijing Jialin Pharma
Qilu Pharmaceutical
Teva Pharma
Cipla
Zydus Cadila
United Biotech
Par Pharma
Khandelwal Laboratories
Alkem (Cytomed)
Samarth Pharma
VHB Life Sciences
Geographically, this report is segmented into several key Regions, with production, consumption, revenue, market share and growth rate of Hydroxycarbamide in these regions, from 2012 to 2022 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East and Africa
On the basis of product, the Hydroxycarbamide market is primarily split into
Capsule
Tablet
On the basis on the end users/applications, this report covers
Sickle Cell Disease
Cancer
Other
1 Hydroxycarbamide Market Overview 1
1.1 Product Overview and Scope of Hydroxycarbamide 1
1.2 Hydroxycarbamide Segment by Types 3
1.2.1 Global Hydroxycarbamide Production Market Share (%) by Types in 2016 3
1.2.2 Capsule 4
1.2.3 Tablet 4
1.3 Global Hydroxycarbamide Segment by Applications 5
1.3.1 Global Hydroxycarbamide Consumption Share by Applications 5
1.3.2 Sickle-cell Disease 6
1.3.3 Cancer 6
1.4 Global Hydroxycarbamide Market by Regions (2012-2022) 7
1.4.1 Global Hydroxycarbamide Market Size and Growth Rate Comparison by Regions (2012-2022) 7
1.4.2 North America Hydroxycarbamide Status and Prospect (2012-2022) 8
1.4.3 Europe Hydroxycarbamide Status and Prospect (2012-2022) 9
1.4.4 Asia Pacific Hydroxycarbamide Status and Prospect (2012-2022) 10
1.4.5 South America Hydroxycarbamide Status and Prospect (2012-2022) 11
1.4.6 Middle East and Africa Hydroxycarbamide Status and Prospect (2012-2022) 12
1.5 Global Hydroxycarbamide Market Size (2012-2022) 13
1.5.1 Global Hydroxycarbamide Revenue Status and Outlook (2012-2022) 13
1.5.2 Global Hydroxycarbamide Production Status and Outlook (2012-2022) 14
2 Global Hydroxycarbamide Market Competition by Manufacturers 15
2.1 Global Hydroxycarbamide Production and Share by Manufacturers (2016-2017) 15
2.2 Global Hydroxycarbamide Revenue and Share by Manufacturers (2016-2017) 17
2.3 Global Hydroxycarbamide Average Price by Manufacturers (2016-2017) 19
2.4 Hydroxycarbamide Market Competitive Situation and Trends 21
2.4.1 Hydroxycarbamide Market Concentration Rate 21
2.4.2 Hydroxycarbamide Market Share of Top 3 and Top 5 Manufacturers 22
2.4.3 Mergers & Acquisitions, Expansion 23
3 Global Hydroxycarbamide Production by Regions (2012-2017) 26
3.1 Global Hydroxycarbamide Production and Market Share by Regions (2012-2017) 26
3.2 Global Hydroxycarbamide Revenue and Market Share by Regions (2012-2017) 28
3.3 Global Hydroxycarbamide Production, Revenue, Price and Gross Margin (2012-2017) 30
3.4 North America Hydroxycarbamide Production (2012-2017) 31
3.4.1 North America Hydroxycarbamide Production and Growth Rate (2012-2017) 31
3.4.2 North America Hydroxycarbamide Production, Revenue, Price and Gross Margin (2012-2017) 31
3.5 Europe Hydroxycarbamide Production (2012-2017) 32
3.5.1 Europe Hydroxycarbamide Production and Growth Rate (2012-2017) 32
3.5.2 Europe Hydroxycarbamide Production, Revenue, Price and Gross Margin (2012-2017) 32
3.6 Asia Pacific Hydroxycarbamide Production (2012-2017) 33
3.6.1 Asia Pacific Hydroxycarbamide Production and Growth Rate (2012-2017) 33
3.6.2 Asia Pacific Hydroxycarbamide Production, Revenue, Price and Gross Margin (2012-2017) 34
3.7 South America Hydroxycarbamide Production (2012-2017) 35
3.7.1 South America Hydroxycarbamide Production and Growth Rate (2012-2017) 35
3.7.2 South America Hydroxycarbamide Production, Revenue, Price and Gross Margin (2012-2017) 35
3.8 Middle East and Africa Hydroxycarbamide Production (2012-2017) 36
3.8.1 Middle East and Africa Hydroxycarbamide Production and Growth Rate (2012-2017) 36
3.8.2 Middle East and Africa Hydroxycarbamide Production, Revenue, Price and Gross Margin (2012-2017) 37
4 Global Hydroxycarbamide Consumption by Regions (2012-2017) 38
4.1 Global Hydroxycarbamide Consumption by Regions (2012-2017) 38
4.2 North America Hydroxycarbamide Consumption (2012-2017) 40
4.3 Europe Hydroxycarbamide Consumption (2012-2017) 41
4.4 Asia Pacific Hydroxycarbamide Consumption (2012-2017) 42
4.5 South America Hydroxycarbamide Consumption (2012-2017) 43
4.6 Middle East and Africa Hydroxycarbamide Consumption (2012-2017) 44
5 Global Hydroxycarbamide Production, Revenue (Value), Price Trend by Types 45
5.1 Global Hydroxycarbamide Production and Market Share by Types (2012-2017) 45
5.2 Global Hydroxycarbamide Revenue and Market Share by Types (2012-2017) 47
5.3 Global Hydroxycarbamide Price by Types (2012-2017) 48
5.4 Global Hydroxycarbamide Production Growth Rate by Types (2012-2017) 49
6 Global Hydroxycarbamide Market Analysis by Applications 50
6.1 Global Hydroxycarbamide Consumption and Market Share by Applications (2012-2017) 50
6.2 Global Hydroxycarbamide Consumption Growth Rate by Applications (2012-2017) 52
7 Global Hydroxycarbamide Manufacturers Profiles/Analysis 53
7.1 Bristol Myers Squibb 53
7.1.1 Company Basic Information, Key Products and Sales Area 53
7.1.2 Hydroxycarbamide Product Overview 54
7.1.3 Bristol Myers Squibb Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 54
7.2 Taj Pharma 55
7.2.1 Company Basic Information, Key Products and Sales Area 55
7.2.2 Hydroxycarbamide Product Overview 56
7.2.3 Taj Pharma Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 56
7.3 Beijing Jialin Pharma 57
7.3.1 Company Basic Information, Key Products and Sales Area 57
7.3.2 Hydroxycarbamide Product Overview 58
7.3.3 Beijing Jialin Pharma Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 58
7.4 Qilu Pharmaceutical 59
7.4.1 Company Basic Information, Key Products and Sales Area 59
7.4.2 Hydroxycarbamide Product Overview 60
7.4.3 Qilu Pharmaceutical Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 60
7.5 Teva Pharma 61
7.5.1 Company Basic Information, Key Products and Sales Area 61
7.5.2 Hydroxycarbamide Product Overview 62
7.5.3 Teva Pharma Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 62
7.6 Cipla 63
7.6.1 Company Basic Information, Key Products and Sales Area 63
7.6.2 Hydroxycarbamide Product Overview 64
7.6.3 Cipla Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 64
7.7 Zydus Cadila 65
7.7.1 Company Basic Information, Key Products and Sales Area 65
7.7.2 Hydroxycarbamide Product Overview 66
7.7.3 Zydus Cadila Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 66
7.8 United Biotech 67
7.8.1 Company Basic Information, Key Products and Sales Area 67
7.8.2 Hydroxycarbamide Product Overview 68
7.8.3 United Biotech Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 68
7.9 Par Pharma 69
7.9.1 Company Basic Information, Key Products and Sales Area 69
7.9.2 Hydroxycarbamide Product Overview 70
7.9.3 Par Pharma Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 71
7.10 Khandelwal Laboratories 71
7.10.1 Company Basic Information, Key Products and Sales Area 71
7.10.2 Hydroxycarbamide Product Overview 72
7.10.3 Khandelwal Laboratories Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 73
7.11 Alkem (Cytomed) 73
7.11.1 Company Basic Information, Key Products and Sales Area 73
7.11.2 Hydroxycarbamide Product Overview 74
7.11.3 Alkem (Cytomed) Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 75
7.12 Samarth Pharma 75
7.12.1 Company Basic Information, Key Products and Sales Area 75
7.12.2 Hydroxycarbamide Product Overview 76
7.12.3 Samarth Pharma Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 76
7.13 VHB Life Sciences 77
7.13.1 Company Basic Information, Key Products and Sales Area 77
7.13.2 Hydroxycarbamide Product Overview 78
7.13.3 VHB Life Sciences Hydroxycarbamide Production, Revenue, Price and Gross Margin (2016-2017) 78
8 Hydroxycarbamide Manufacturing Cost Analysis 79
8.1 Hydroxycarbamide R&D Cost Analysis 79
8.1.1 Clinical Phase Costs 80
8.1.2 Capitalized Costs 81
8.2 Proportion of Manufacturing Cost Structure 82
8.2.1 Raw Materials 82
8.2.2 Labor Cost 83
8.2.2.1 USA Labor Cost Analysis 84
8.2.2.2 Europe Labor Costs Analysis 86
8.2.2.3 Asia Labor Costs Analysis 88
8.2.3 Other Costs Analysis 90
8.2.3.1 USA Other Cost Analysis 90
8.2.3.2 Europe Other Cost Analysis 91
8.2.3.3 China Other Cost Analysis 92
8.3 Manufacturing Process Analysis of Hydroxycarbamide 94
9 Industrial Chain, Sourcing Strategy and Downstream Buyers 95
9.1 Hydroxycarbamide Industrial Chain Analysis 95
9.2 Upstream Raw Materials Sourcing 95
9.3 Downstream Buyers 96
10 Marketing Strategy Analysis, Distributors/Traders 97
10.1 Marketing Channel 97
10.1.1 Direct Marketing 97
10.1.2 Indirect Marketing 98
10.1.3 Marketing Channel Development Trend 98
10.2 Market Positioning 98
10.2.1 Pricing Strategy 98
10.2.2 Brand Strategy 99
10.2.2.1 Introducing Pharmaceutical Branding Strategies 99
10.2.2.2 Building Pharmaceutical Brands 100
10.2.2.3 Communicating Pharmaceutical Brands 101
10.2.2.4 Alternative Brand Models 101
10.2.2.5 The Future of Pharmaceutical Branding 102
10.3 Distributors/Traders List 103
11 Market Effect Factors Analysis 104
11.1 Technology Progress/Risk 104
11.1.1 Substitutes Threat 104
11.1.2 Technology Progress in Related Industry 104
11.2 Consumer Needs/Customer Preference Change 104
11.3 Economic/Political Environmental Change 105
12 Global Hydroxycarbamide Market Forecast (2017-2022) 114
12.1 Global Hydroxycarbamide Production, Revenue Forecast (2017-2022) 114
12.1.1 Global Hydroxycarbamide Production (M Unit) and Growth Rate (%) Forecast (2017-2022) 114
12.1.2 Global Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 115
12.1.3 Global Hydroxycarbamide Price and Trend Forecast (2017-2022) 116
12.2 Global Hydroxycarbamide Production (M Unit) Forecast by Regions (2017-2022) 116
12.2.1 North America Hydroxycarbamide Production (M Unit) and Revenue (M USD) Forecast (2017-2022) 117
12.2.2 Europe Hydroxycarbamide Production (M Unit), Revenue (M USD) Forecast (2017-2022) 119
12.2.3 Asia-Pacific Hydroxycarbamide Production (M Unit), Revenue (M USD) Forecast (2017-2022) 121
12.2.4 South America Hydroxycarbamide Production (M Unit), Revenue (M USD) Forecast (2017-2022) 123
12.2.5 Middle East and Africa Hydroxycarbamide Production (M Unit), Revenue (M USD) Forecast (2017-2022) 125
12.3 Global Hydroxycarbamide Consumption (M Unit) Forecast by Regions (2017-2022) 126
12.3.1 North America Hydroxycarbamide Consumption (M Unit) Forecast (2017-2022) 128
12.3.2 Europe Hydroxycarbamide Consumption (M Unit) Forecast (2017-2022) 129
12.3.3 Asia-Pacific Hydroxycarbamide Consumption (M Unit) Forecast (2017-2022) 130
12.3.4 South America Hydroxycarbamide Consumption (M Unit) Forecast (2017-2022) 131
12.3.5 Middle East and Africa Hydroxycarbamide Consumption (M Unit) Forecast (2017-2022) 132
12.4 Global Hydroxycarbamide Production, Revenue and Price Forecast by Type (2017-2022) 132
12.5 Global Hydroxycarbamide Consumption Forecast by Application (2017-2022) 133
13 Research Findings and Conclusion 135
14 Methodology and Data Source 136
14.1 Methodology/Research Approach 136
14.1.1 Research Programs/Design 136
14.1.2 Market Size Estimation 137
14.2 Data Source 139
14.2.1 Secondary Sources 139
14.2.2 Primary Sources 140
14.3 Disclaimer 141
14.4 Author List 142
Figure Product Picture of Hydroxycarbamide 1
Table Hydroxycarbamide Product Specification 1
Figure Global Hydroxycarbamide Production Market Share (%) by Types in 2016 3
Figure Product Picture of Capsule 4
Figure Product Picture of Tablet 4
Figure Global Hydroxycarbamide Consumption (M Unit) Market Share (%) by Applications in 2016 5
Figure Sickle-cell Disease Examples 6
Figure Cancer Examples 6
Figure Global Hydroxycarbamide Market Size (M USD) Comparison and Growth Rate by Regions (2012-2022) 7
Figure North America Hydroxycarbamide Revenue (M USD) and Growth Rate (2012-2022) 8
Figure Europe Hydroxycarbamide Revenue (M USD) and Growth Rate (2012-2022) 9
Figure Asia Pacific Hydroxycarbamide Revenue (M USD) and Growth Rate (2012-2022) 10
Figure South America Hydroxycarbamide Revenue (M USD) and Growth Rate (2012-2022) 11
Figure Middle East and Africa Hydroxycarbamide Revenue (M USD) and Growth Rate (2012-2022) 12
Figure Global Hydroxycarbamide Revenue (M USD) Status and Outlook (2012-2022) 13
Figure Global Hydroxycarbamide Production (M Unit) Status and Outlook (2012-2022) 14
Table Global Hydroxycarbamide Production (M Unit) of Key Manufacturers (2016-2017) 15
Table Global Hydroxycarbamide Production Market Share by Manufacturers (2016-2017) 15
Figure 2016 Hydroxycarbamide Production Market Share by Manufacturers 16
Figure 2017 Hydroxycarbamide Production Market Share by Manufacturers 17
Table Global Hydroxycarbamide Revenue (M USD) by Manufacturers (2016-2017) 17
Table Global Hydroxycarbamide Revenue Share by Manufacturers (2016-2017) 18
Figure 2016 Global Hydroxycarbamide Revenue Share by Manufacturers 18
Figure 2017 Global Hydroxycarbamide Revenue Share by Manufacturers 19
Table Global Market Hydroxycarbamide Average Price (USD/K Unit) of Key Manufacturers (2016-2017) 19
Figure Global Market Hydroxycarbamide Average Price (USD/K Unit) of Key Manufacturers in 2016 20
Figure 2016 Hydroxycarbamide Production Market Share by Manufacturers 21
Figure Hydroxycarbamide Revenue Market Share of Top 3 Manufacturers in 2016 22
Figure Hydroxycarbamide Revenue Market Share of Top 5 Manufacturers in 2016 23
Table Global Hydroxycarbamide Production (M Unit) by Regions (2012-2017) 26
Table Global Hydroxycarbamide Production Market Share by Regions (2012-2017) 26
Figure Global Hydroxycarbamide Production Market Share by Regions (2012-2017) 27
Figure 2016 Global Hydroxycarbamide Production Market Share by Regions 27
Table Global Hydroxycarbamide Revenue (M USD) by Regions (2012-2017) 28
Table Global Hydroxycarbamide Revenue Market Share by Regions (2012-2017) 28
Figure Global Hydroxycarbamide Revenue Market Share by Regions (2012-2017) 29
Figure 2016 Global Hydroxycarbamide Revenue Market Share by Regions 29
Figure Global Hydroxycarbamide Production (M Unit) and Growth Rate (2012-2017) 30
Table Global Hydroxycarbamide Production (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2012-2017) 30
Figure North America Hydroxycarbamide Production (M Unit) and Growth Rate (2012-2017) 31
Table North America Hydroxycarbamide Production (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2012-2017) 31
Figure Europe Hydroxycarbamide Production (M Unit) and Growth Rate (2012-2017) 32
Table Europe Hydroxycarbamide Production (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2012-2017) 32
Figure Asia Pacific Hydroxycarbamide Production (M Unit) and Growth Rate (2012-2017) 33
Table Asia Pacific Hydroxycarbamide Production (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2012-2017) 34
Figure South America Hydroxycarbamide Production (M Unit) and Growth Rate (2012-2017) 35
Table South America Hydroxycarbamide Production (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2012-2017) 35
Figure Middle East and Africa Hydroxycarbamide Production (M Unit) and Growth Rate (2012-2017) 36
Table Middle East and Africa Hydroxycarbamide Production (M Unit), Revenue (M USD), Price (USD/K Unit) and Gross Margin (2012-2017) 37
Table Global Hydroxycarbamide Consumption (M Unit) Market by Regions (2012-2017) 38
Table Global Hydroxycarbamide Consumption Market Share by Regions (2012-2017) 38
Figure Global Hydroxycarbamide Consumption Market Share by Regions (2012-2017) 39
Figure 2016 Global Hydroxycarbamide Consumption Market Share by Regions 39
Figure North America Hydroxycarbamide Consumption (M Unit) and Growth Rate (2012-2017) 40
Figure Europe Hydroxycarbamide Consumption (M Unit) and Growth Rate (2012-2017) 41
Figure Asia Pacific Hydroxycarbamide Consumption (M Unit) and Growth Rate (2012-2017) 42
Figure South America Hydroxycarbamide Consumption (M Unit) and Growth Rate (2012-2017) 43
Figure Middle East and Africa Hydroxycarbamide Consumption (M Unit) and Growth Rate (2012-2017) 44
Table Global Hydroxycarbamide Production (M Unit) by Types (2012-2017) 45
Table Global Hydroxycarbamide Production Market Share by Types (2012-2017) 45
Figure Production Market Share of Hydroxycarbamide by Types (2012-2017) 46
Figure 2016 Production Market Share of Hydroxycarbamide by Types 46
Table Global Hydroxycarbamide Revenue (M USD) by Types (2012-2017) 47
Table Global Hydroxycarbamide Revenue Share by Types (2012-2017) 47
Figure Revenue Share of Hydroxycarbamide by Types (2012-2017) 47
Figure 2016 Revenue Market Share of Hydroxycarbamide by Types 48
Table Global Hydroxycarbamide Price (USD/K Unit) by Types (2012-2017) 48
Figure Global Hydroxycarbamide Production Growth Rate by Types (2012-2017) 49
Table Global Hydroxycarbamide Consumption (M Unit) by Applications (2012-2017) 50
Table Global Hydroxycarbamide Consumption Market Share by Applications (2012-2017) 50
Figure Global Hydroxycarbamide Consumption Market Share by Applications (2012-2017) 51
Figure Global Hydroxycarbamide Consumption Market Share by Applications in 2016 51
Figure Global Hydroxycarbamide Consumption Growth Rate by Applications (2012-2017) 52
Table Bristol Myers Squibb Basic Information, Key Products and Sales Area 53
Figure Hydroxycarbamide Product Overview 54
Table Bristol Myers Squibb Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 54
Table Taj Pharma Basic Information, Key Products and Sales Area 55
Figure Hydroxycarbamide Product Overview 56
Table Taj Pharma Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 56
Table Beijing Jialin Pharma Basic Information, Key Products and Sales Area 57
Figure Hydroxycarbamide Product Overview 58
Table Beijing Jialin Pharma Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 58
Table Qilu Pharmaceutical Basic Information, Key Products and Sales Area 59
Figure Hydroxycarbamide Product Overview 60
Table Qilu Pharmaceutical Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 60
Table Teva Pharma Basic Information, Key Products and Sales Area 61
Figure Hydroxycarbamide Product Overview 62
Table Teva Pharma Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 62
Table Cipla Basic Information, Key Products and Sales Area 63
Figure Hydroxycarbamide Product Overview 64
Table Cipla Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 64
Table Zydus Cadila Basic Information, Key Products and Sales Area 65
Figure Hydroxycarbamide Product Overview 66
Table Zydus Cadila Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 66
Table United Biotech Basic Information, Key Products and Sales Area 67
Figure Hydroxycarbamide Product Overview 68
Table United Biotech Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 68
Table Par Pharma Basic Information, Key Products and Sales Area 69
Figure Hydroxycarbamide Product Overview 70
Table Par Pharma Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 71
Table Khandelwal Laboratories Basic Information, Key Products and Sales Area 71
Figure Hydroxycarbamide Product Overview 72
Table Khandelwal Laboratories Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 73
Table Alkem (Cytomed) Basic Information, Key Products and Sales Area 73
Table Hydroxycarbamide Product Overview 74
Table Alkem (Cytomed) Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 75
Table Samarth Pharma Basic Information, Key Products and Sales Area 75
Table Hydroxycarbamide Product Overview 76
Table Samarth Pharma Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 76
Table VHB Life Sciences Basic Information, Key Products and Sales Area 77
Table Hydroxycarbamide Product Overview 78
Table VHB Life Sciences Hydroxycarbamide Production (M Units), Revenue (M USD), Price (USD/K Unit) and Gross Margin (%) (2016-2017) 78
Figure Typical Phases from Research to the Market for a Drug Candidate 80
Table Out-of-pocket Preclinical and Clinical Period Cost per Investigational Hydroxycarbamide Compound 81
Table Capitalized Preclinical and Clinical Period Costs per Investigational Hydroxycarbamide Compound 82
Table Manufacturing Cost Structure of Hydroxycarbamide 82
Figure Assessment of API Manufacturing Cost By Region 83
Figure USA Overview of Average Hourly Wages 2015-2016 (USD/Hour) 84
Figure USA Overview of Labor Costs 2013-2016 (110 Index Points) 84
Figure Cost of Employing a Factory Worker 86
Figure 2015 Estimated Labor Costs for the Whole Economy in Europe 87
Figure Monthly Minimum Wages in Asia 2016 88
Figure China Overview of Average Yearly Wages 2015-2016 (CNY/Year) 89
Figure Japan Overview of Average Monthly Wages 2015-2016(JPY Thousand/Month) 89
Table Average Price of Electricity to Ultimate Customers 90
Figure Electricity Prices for Household Consumers in 2015 91
Figure Summary of the Driving Assumptions 92
Figure Industrial Electric Rates 2015 (PER KWH) 93
Figure Manufacturing Process Analysis of Hydroxycarbamide 94
Figure Hydroxycarbamide Industrial Chain Analysis 95
Figure Marketing Channel 97
Table Distributors/Traders List 103
Figure Global GDP Growth Rate for 2015 105
Figure US GDP 2006-2016 (Billion USD) 106
Figure US CPI Change 2016-2017 107
Figure EU GDP 2006-2016 (Billion USD) 107
Figure EU CPI Change 2012-2016 108
Figure Germany GDP 2006-2016 (Billion USD) 108
Figure Germany CPI Change 2016-2017 109
Figure UK GDP 2006-2016 (Billion USD) 109
Figure UK CPI Change 2016-2017 110
Figure Italy GDP 2006-2016 (Billion USD) 110
Figure Italy CPI Change 2016-2017 111
Figure Japan GDP 2006-2016 (Billion USD) 111
Figure Japan CPI Change 2012-2016 112
Figure China GDP 2006-2016 (Billion USD) 112
Figure China CPI Change 2016-2017 113
Figure Global Hydroxycarbamide Production (M Unit) and Growth Rate (%) Forecast (2017-2022) 114
Figure Global Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 115
Figure Global Hydroxycarbamide Price and Trend Forecast (2017-2022) 116
Table Global Hydroxycarbamide Production (M Unit) Forecast by Regions (2017-2022) 116
Table Global Hydroxycarbamide Revenue (M USD) Forecast by Regions (2017-2022) 117
Figure North America Hydroxycarbamide Production (M Unit) and Growth Rate (%) Forecast (2017-2022) 117
Figure North America Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 118
Figure Europe Hydroxycarbamide Production (M Unit) and Growth Rate Forecast (2017-2022) 119
Figure Europe Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 120
Figure Asia-Pacific Hydroxycarbamide Production (M Unit) and Growth Rate (%) Forecast (2017-2022) 121
Figure Asia-Pacific Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 122
Figure South America Hydroxycarbamide Production (M Unit) and Growth Rate (%) Forecast (2017-2022) 123
Figure South America Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 124
Figure Middle East and Africa Hydroxycarbamide Production (M Unit) and Growth Rate (%) Forecast (2017-2022) 125
Figure Middle East and Africa Hydroxycarbamide Revenue (M USD) and Growth Rate (%) Forecast (2017-2022) 126
Table Global Hydroxycarbamide Consumption (M Unit) Forecast by Regions (2017-2022) 126
Figure Global Hydroxycarbamide Consumption Market Share (%) Forecast by Regions (2017-2022) 127
Figure North America Hydroxycarbamide Consumption (M Unit) and Growth Rate (%) Forecast (2017-2022) 128
Figure Europe Hydroxycarbamide Consumption (M Unit) and Growth Rate (%) Forecast (2017-2022) 129
Figure Asia-Pacific Hydroxycarbamide Consumption (M Unit) and Growth Rate (%) Forecast (2017-2022) 130
Figure South America Hydroxycarbamide Consumption (M Unit) and Growth Rate (%) Forecast (2017-2022) 131
Figure Middle East and Africa Hydroxycarbamide Consumption (M Unit) and Growth Rate (%) Forecast (2017-2022) 132
Table Global Hydroxycarbamide Production (M Unit) Forecast by Type (2017-2022) 132
Figure Global Hydroxycarbamide Production Forecast by Type (2017-2022) 132
Table Global Hydroxycarbamide Revenue (M USD) Forecast by Type (2017-2022) 133
Table Global Hydroxycarbamide Revenue Market Share (%) Forecast by Type (2017-2022) 133
Table Global Hydroxycarbamide Price (USD/K Unit) Forecast by Type (2017-2022) 133
Table Global Hydroxycarbamide Consumption (M Unit) Forecast by Application (2017-2022) 133
Figure Global Hydroxycarbamide Consumption Forecast by Application (2017-2022) 134
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...